ClinicalTrials.gg
RecruitingNCT06900985TREATINTSMOKEUpdated Oct 23, 2026

Therapeutic Contact Intensity in a Psychological Smoking Cessation Intervention With an App

An interventional study of 8-sessions CBT + App and 4-sessions CBT+App in Smoking Behaviors, sponsored by University of Santiago de Compostela. Recruiting at 1 site in Spain. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by University of Santiago de Compostela · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Sep 2026; still recruiting 2 months later.
Updated Oct 23, 2026Now RecruitingSite recruiting status changedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
429
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 27 studies in Smoking with a site in Spain — 4 open to participants now, 5 under way, none of them phase 3. Smoking · Spain.

Planned enrollment
9th of 19
429 · median 408
Started
2026
the only one that year
No phase
15 of 27
4 open now
Registered
25th of 27
by date
Lead sponsor
3 of 27
University of Santiago de Compostela

Among the 27 studies in Smoking with a site in Spain, this one is the 9th largest by planned enrollment of the 19 interventional ones that give a count, is the only one that started in 2026, is one of 15 with no phase, and was the 25th registered.

Smoking

1,516 studies on the registry are indexed under Smoking; 196 are open to participants now.

Browse Smoking studies →

Open to participants now

4 of the 27 studies in Smoking with a site in Spain are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 145 Smoking studies recruiting now, 76 (52%) set no upper age limit and 51 (35%) stop at 75 or younger; 3 take children under 18; 69 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 27 studies in Smoking with a site in Spain, or all of them as a file.
02

Study summary

This randomized controlled trial intends to examine the efficacy of a smoking cessation intervention with an App according to the intensity of therapeutic contact. Participants will be assigned to one of three groups. The first group will receive eight sessions with trained psychologists alongside access to the App. The second group will receive four sessions with trained psychologists plus App access. The control group will only have access to the App. This study seeks to determine the impact of different levels of therapeutic contact on abstinence outcomes.

Read the detailed description

Smoking remains the leading preventable cause of morbidity and mortality worldwide. It is crucial to implement preventive measures to reduce the likelihood of people starting to smoke but also to make effective smoking cessation treatments available to those who smoke. Psychological interventions have proven to be effective to quit smoking and are considered first-choice interventions, especially for specific populations such as adolescents or pregnant women . The motivation behind this proposal is to improve the effectiveness of smoking cessation treatments based on our clinical and research experience in smoking cessation psychological interventions. Although we have very effective psychological treatments, producing abstinence rates of approximately 70% at the end of the treatment, and 35% at one year of follow-up to continue improving its effectiveness and reduce relapse rates is warranted. Furthermore, technological advances can help increase accessibility to available treatments and motivation to participate in smoking cessation interventions.

The main objective of this proposal is to assess the efficacy of a cognitive-behavioral treatment for smoking cessation with new components (anhedonia and mood management, physical activity, and positive social support) according to the intensity of the therapeutic contact, through a randomized controlled trial. The treatment will be conducted through video call format to make it more accessible. The study will compare three groups that will receive treatments of varying intensity of therapeutic contact: 1) 8 intervention sessions + App (Experimental Group 1, EG1), 2) 4 intervention sessions + App (Experimental Group 2, G2), and 3) no therapeutic contact, App only (control group/CG). Our initial hypothesis is that the higher intensity intervention (EG1) will be more effective than EG2 and CG groups in abstinence outcomes at the end of the intervention and in reducing relapse rates for one year follow-up. The EG2 will be more effective than the CG in abstinence outcomes at the end of the intervention and in reducing relapse rates during one-year follow-up.

Digital treatment delivery formats will be used to increase treatment accessibility: 1) treatment sessions will be conducted through video calls which will remove geographical and time-related barriers. This format will be particularly useful for smokers experiencing barriers to access to treatment due to work/family schedules; 2) a smoking cessation App will be used to improve adherence and access to treatment components anytime, anywhere. Moreover, integrating technology into the treatment can facilitate participants intersessions tasks and support the work of professionals. Our previous experience with an App as a complement to the smoking cessation intervention showed excellent abstinence outcomes.

03

Conditions studied

  • Smoking Behaviors

Browse trials for

Keywords

  • smoking
  • treatment
  • cognitive-behavioral
  • therapeutic-contact intensity
  • digital intervention
  • eHealth
  • randomized controlled trial
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • aged 18 or over
  • wishing to participate in the treatment
  • providing written
  • smoking at least 5 cigarettes per day
  • completion of all pre-treatment assessment questionnaires
  • having a valid email address
  • having an Android or iOS smartphone and being willing to use it throughout the treatment

Exclusion criteria

Exclusion Criteria:

  • a diagnosis of severe mental disorder (bipolar disorder and/or psychotic disorder)
  • concurrent substance use disorder (alcohol, cannabis, stimulant, hallucinogen and/or opioid)
  • using other tobacco products (electronic cigarette with nicotine, cigars or cigarillos)
  • having completed an effective psychological treatment to quit smoking during the previous year
  • having completed a pharmacological treatment to quit smoking in the last year (any smoking cessation medication approved by the Agencia Española del Medicamento)
  • having a physical pathology involving high vital risk that requires immediate intervention (e.g., recent myocardial infarction)
  • having visual difficulties that prevent the use of the App.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
429 participants (estimated)

Study arms

  • Active comparator
    1. High-intensity therapeutic contact cognitive-behavioral treatment for smoking cessation with App

    It will consist of an App and 8 one-hour sessions applied in group format once a week (8 weeks total duration). The sessions will be conducted by trained clinical psychology/general health psychology professionals and will be carried out using video calls.

    Behavioral: 8-sessions CBT + App

  • Active comparator
    2. Medium-intensity therapeutic contact CBT for smoking cessation with App

    It will consist of an App and 4 one-hour sessions applied in group format every two-weeks (8 weeks total duration). The sessions will be conducted by trained clinical psychology/general health psychology professionals and will be carried out using video calls.

    Behavioral: 4-sessions CBT+App

  • Active comparator
    3. App only (no therapeutic-contact group).

    It will consist of the same App than participants assigned to Conditions 1 and 2, but without contact with professionals

    Behavioral: Smoking cessation App

Interventions

  • Behavioral8-sessions CBT + App

    It will consist of 8 one-hour sessions applied in group format once a week and participants will be followed at 3, 6, and 12 months. The sessions will be conducted by clinical psychology/general health psychology professionals and will be carried out using video calls. The smoking cessation treatment follows a cognitive-behavioral approach with components for anhedonia reduction, increased physical activity and positive social support, being a modified, multidisciplinary, and extended version of the original smoking cessation program (Becoña, 2007; Becoña et al., 2017). The treatment will be complemented with an App with active therapeutic components that participants will use during treatment and the one-year follow-up period.

  • Behavioral4-sessions CBT+App

    It will consist of 4 one-hour sessions applied in group format every two-weeks (8 weeks total duration) and participants will be followed at 3, 6, and 12 months. The sessions will be conducted by clinical psychology/general health psychology professionals and will be carried out using video calls. The 4 sessions will have the following content: 1) explanation of treatment rationale and components available in the App; 2) participants' progress monitoring, reinforcement of achieved goals, and analysis of difficulties; 3) cessation planning support; and 4) relapse prevention support. The treatment sessions will be protocolized in a treatment manual. The treatment will be complemented with the same App that the other conditions

  • BehavioralSmoking cessation App

    It will consist in the same App than the other two conditions. No therapeutic contact will be avaliable.

06

What researchers measure

Primary outcomes

  1. 7-days point prevalence abstinence

    The abstinent status will be defined as not having smoked in the last 7 days (not even a puff)

    Time frame: At 12-months post-intervention

Secondary outcomes

  1. 7-days point prevalence

    The abstinent status will be defined as not having smoked in the last 7 days (not even a puff)

    Time frame: At 3 and 6-months post-intervention

  2. 7-days point prevalence abstinence

    The abstinent status will be defined as not having smoked in the last 7 days (not even a puff)

    Time frame: At 7-days post-quit day

  3. Satisfaction with the intervention

    Scores obtained in Client Satisfaction Questionnaire (CSQ-8; Larsen et al., 19979; Spanish version of Vázquez et al., 2017)

    Time frame: At 8-weeks after beginning the intervention

07

Study locations

1 of 1 sites recruiting
  • Smoking Cessation and Addictive Disorders Unit
    Santiago de Compostela, A Coruña 15885, Spain
    Recruiting
08

References and documents

Publications

  • Lopez-Duran A, Martinez-Vispo C, Martinez U, Rodriguez-Cano R, Cortes-Garcia L, Miguez MC, Barroso-Hurtado M, Ramos-Carro M, Moss-Alonso E, Vacas J, Millara L, Tubio A, Becona E. Therapeutic contact intensity as an adjunct to a cognitive behavioral smoking cessation app: protocol for a randomized controlled trial. Addict Sci Clin Pract. 2026 Jun 11. doi: 10.1186/s13722-026-00684-0. Online ahead of print. PubMed 42271518 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2026 (actual). Primary completion is estimated for Apr 2028, 19 months after the start.

Of 405 non-industry interventional studies with no phase under Smoking, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 42. This study's planned 19 months is below that.

Counting every sponsor, half of 461 studies reached it within 23 months; a quarter within 8 and three quarters within 40.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 21, 2025
First posted
Mar 28, 2025
StartActual
Sep 1, 2026
Primary completionEst.
Apr 2028
CompletionEst.
Apr 2028
Last update
Oct 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 23, 2026
Sites
Smoking Cessation and Addictive Disorders Unit is now Recruiting
Oct 23, 2026
Show all 1 update
  1. Oct 23, 2026
    Not yet recruiting→Recruiting
    Smoking Cessation and Addictive Disorders Unit is now Recruiting
    + 3 other changes: verification date, date precision and references

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06900985
Lead sponsor
University of Santiago de Compostela
Responsible party
Ana López Durán (Phd in Clinical Psychology and Psychobiology/Associated Professor, University of Santiago de Compostela) — Principal investigator
First posted
Mar 28, 2025
Start date
Sep 1, 2026
Primary completion
Apr 2028 (estimated)
Completion
Apr 2028 (estimated)
Last update
Oct 23, 2026

Study contacts

Ana López-Durán, Phd.
Contact
ana.lopez@usc.es
+34 881813774
Ana López-Durán, Phd.
principal investigator · University of Santiago de Compostela
Elisardo Becoña Iglesias, Phd.
principal investigator · University of Santiago de Compostela

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion